<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ability of leucocytes to adhere to endothelium is essential for leucocyte migration into inflammatory sites </plain></SENT>
<SENT sid="1" pm="."><plain>Some of these <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules are released from the cell surface and can be detected in serum </plain></SENT>
<SENT sid="2" pm="."><plain>The soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 (ICAM-1), E selectin, and vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 (VCAM-1) were studied in the serum of patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, and healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>A second blood sample was taken from patients with active disease after one month of treatment and a third two months after remission was achieved </plain></SENT>
<SENT sid="4" pm="."><plain>Tissue expression of the same <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules was studied by immunohistology </plain></SENT>
<SENT sid="5" pm="."><plain>Circulating VCAM-1 concentrations were significantly higher in patients with active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (n = 11, median = 165 U/ml) compared with patients with inactive <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (n = 10, median = 117 U/ml, p &lt; 0.005), active <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (n = 12, median = 124 U/ml, p &lt; 0.02), and controls (n = 90, median = 50 U/ml, p &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Within each disease group there were no significant differences in E selectin or ICAM-1 concentrations between the active and inactive states, however, patients with active <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> had significantly higher ICAM-1 concentrations (n = 12, median = 273 ng/ml) than controls (n = 28, median = 168, p &lt; 0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>VCAM-1 concentrations fell significantly from pretreatment values to remission in active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (p &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> there was a significant fall in ICAM-1 both during treatment (p &lt; 0.01) and two months after remission (p &lt; 0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>Vascular expression of ICAM-1 occurred more often and was more intense in inflamed tissue sections from patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> than from controls </plain></SENT>
<SENT sid="10" pm="."><plain>Vascular labelling with antibody to E selectin also occurred more often in patients with active <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, increased circulating concentrations of selected <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules are associated with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>There is also evidence of local upregulation, particularly of ICAM-1 </plain></SENT>
<SENT sid="13" pm="."><plain>Differential expression of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules in tissue may play a part in the initiation of leucocyte migration and local <z:mp ids='MP_0001845'>inflammation</z:mp>; the function of circulating <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules is unknown, but may play a physiological part in blocking <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
</text></document>